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Abstract  
Background: Campaigns aimed at raising cancer awareness and encouraging early 
presentation have been implemented in England. However, little is known about whether 
people with low cancer awareness and increased barriers to seeking medical help have worse 
cancer survival, and whether there is a geographical variation in cancer awareness and 
barriers in England. 
Methods: From population-based surveys (n=35,308), using the Cancer Research UK Cancer 
Awareness Measure, we calculated the age- and sex -standardised symptom awareness and 
barriers scores for 52 Primary Care Trusts (PCTs). These measures were evaluated in relation 
to the sex-, age-, and type of cancer - standardised cancer survival index of the corresponding 
PCT, from the National Cancer Registry, using linear regression. Breast, lung, and bowel 
cancer survival were analysed separately.  
Results: Cancer symptom awareness and barriers scores varied greatly between 
geographical regions in England, with the worst scores observed in socio-economically 
deprived parts of East London. Low cancer awareness score was associated with poor cancer 
survival at PCT level (estimated slope=1.56, 95%CI: 0.56; 2.57). The barriers score was not 
associated with overall cancer survival, but it was associated with breast cancer survival 
(estimated slope=-0.66, 95%CI: -1.20; -0.11). Specific barriers, such as embarrassment and 
difficulties in arranging transport to the doctor’s surgery, were associated with worse breast 
cancer survival.  
Conclusions: Cancer symptom awareness and cancer survival are associated. Campaigns 
should focus on improving awareness about cancer symptoms, especially in socio-
economically deprived areas. Efforts should be made to alleviate barriers to seeking medical 
help in women with symptoms of breast cancer.  
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INTRODUCTION  
Cancer accounts for more than 130,000 deaths each year in England (Office for National 
Statistics, 2012a). Survival for most types of cancer is lower in England than in comparable 
Western European countries (Berrino et al, 2007), and in other high-income countries, such 
as Canada and Australia (Coleman et al, 2011). The National Health Service (NHS) in England 
has introduced several cancer plans, highlighting early diagnosis as a key strategy to improve 
cancer survival (Department of Health, 2000; Department of Health, 2011; Department of 
Health, 2014). Since Improving Outcomes: A Strategy for Cancer in 2011, more than £450 
million has been invested in raising cancer awareness and encouraging early diagnosis in 
England (Department of Health, 2014). A number of ‘Be Clear on Cancer’ campaigns were 
developed to improve recognition of early symptoms and encourage prompt visits to the doctor 
for the most common types of cancer, such as breast, lung and bowel cancer (Cancer 
Research UK, 2015). The underlying assumption was that survival would be improved if 
people recognised symptoms early, and sought medical help before developing advanced-
stage cancer. Short-term survival is particularly sensitive to stage of disease and therefore to 
timeliness of cancer diagnosis. 
It is not clear what effect, if any, cancer awareness and barriers to help-seeking have on 
cancer survival. The most appropriate research design to address this question would be a 
prospective, cohort study examining the predictive value of symptom recognition or barriers to 
help-seeking on cancer survival. Such a study has not yet been carried out. It is also difficult 
to assess the effects of intermediary factors, such as time from the onset of symptoms to 
presentation, time from presentation to starting a treatment, stage of disease, and types of 
treatment. Ironmonger et al (2014) evaluated the first national campaign and a regional 
campaign in England, both aimed at raising public awareness of a persistent cough as a lung 
cancer symptom. They reported an increase in cancer awareness, a shift to earlier stage at 
diagnosis, and a higher surgical resection rate after both campaigns, compared with one year 
before. Data on survival were available only for the regional campaign, and suggested a 
statistically non-significant increase in one-year survival in the pilot compared with control 
areas.     
Evidence suggests a wide geographical variation in cancer survival in England, with lower 
survival in the north compared to the south of the country (Quaresma et al, 2011; Walters et 
al, 2011). Quaresma et al (2011) showed that the geographical variation in one-year cancer 
survival at Primary Care Trust (PCT) level is constant year-on-year, from 1996 to 2009. PCTs 
were the statutory NHS bodies, structured as small geographical areas, responsible for 
commissioning and providing most health services in England until 2013 (NHS, 2012). Walters 
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et al (2011) reported the same geographical patterns, with generally lower cancer survival in 
northern England, for patients diagnosed between 1991 and 2006, using Cancer Network 
areas. These studies analysed survival from the most common types of cancer, such as lung, 
breast and bowel.  
To explore reasons for variation in cancer survival between countries with similar health care 
systems, including Australia, Canada, Denmark, Norway, Sweden, and the UK, Forbes et al 
(2013) examined differences in cancer awareness and barriers to help-seeking. While the UK, 
with the lowest cancer survival, had low average cancer awareness and the highest barriers, 
there was no consistent pattern across the participating countries. For example, Denmark, 
also with poor cancer survival, had low levels of barriers. However, it may be difficult to detect 
any patterns at an international level. The assessment of differences in cancer awareness and 
barriers by much smaller geographical region in a single country may offer a more salient 
explanation of cancer survival differences. This study aimed to identify how cancer symptom 
awareness and barriers to help-seeking vary by small geographical region (PCT) in England, 
and whether average levels of awareness and barriers are associated with cancer survival at 
PCT level.  
METHODS 
Material  
Data from population-based surveys, using the Cancer Research UK Cancer Awareness 
Measure across England (n=49,270), were linked with cancer survival data from the National 
Cancer Registry at the Office for National Statistics. These two datasets were linked based on 
matching by the relevant geographical area (PCT) in England. To make the matching 
procedure more reliable we used cancer survival data of patients diagnosed in 2010 only, 
because most CAM surveys were conducted in that year (range 2009 to 2011). This meant 
that both patients and survey participants would have been exposed to the same media health 
messages and local cancer awareness campaigns, delivered in their area of residence up to 
2010.  
On one side, we used data from the surveys, described in detail elsewhere (Niksic et al, 2015), 
carried out in 92 PCTs out of the 151 PCTs in England at the time. The response rate was 
51%. The surveys questions used to assess cancer symptom awareness (summed up 
recognition of nine cancer symptoms) and barriers to help-seeking (summed up reporting of 
ten barriers to help-seeking) are available in Supplement 1. 
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To allow reliable calculations of awareness and barriers scores, we included only 52 PCTs, 
which had at least 90 participants in total, with available data in each sex and age category 
(15-44; 45-54; 55-64; 65-74; and 75+ years). To calculate the symptom awareness score, for 
each participant we added up the positive responses (‘Yes’) to the questions about the 
recognition of nine cancer symptoms (Niksic et al, 2015). We then calculated the arithmetic 
mean of this score for each combination of PCT, sex and age group. We took the same 
approach with calculating the barriers score, using positive responses (‘Yes often’ or ‘Yes 
sometimes’) to questions about ten barriers to help-seeking. To standardise the awareness 
and barriers scores by age and sex, we used the age and sex weights developed by the 
Cancer Research UK Cancer Survival Group, at London School of Hygiene and Tropical 
Medicine. The same weights were also used for the calculation of cancer survival index (and 
site-specific indices). The only difference between these weights was that cancer survival 
indices were also weighted for the type of cancer. This made the comparison between the 
awareness and barriers score and cancer survival indices more reliable. It also allowed us to 
avoid using the same weights for the elderly and the young people living in each PCT, who 
have different risks of being diagnosed with cancer and different cancer survival. The same 
approach was used with calculating individual symptoms and barriers. 
On the other side, we used data from the National Cancer Registry to calculate net cancer 
survival. Net survival was defined as survival from a cancer of interest in the absence of death 
from other causes, estimated from population life tables (Perme et al, 2012). The life tables 
were stratified by every year of age, sex and socio-economic deprivation categories for the 
calendar years 2010 to 2011, and developed by Cancer Research UK Cancer Survival Group, 
at the London School of Hygiene and Tropical Medicine. The survival index was calculated as 
one-year net survival for all cancers combined, except non-melanoma skin and prostate 
cancer, standardised for type of cancer, sex, and age, in five age categories (15-44; 45-54; 
55-64; 65-74; and 75+years) for patients diagnosed in 2010 and followed up until 2011. 
Patients diagnosed with non-melanoma skin cancer were excluded because these 
malignancies are rarely fatal and extremely rarely linked with metastases (NCIN, 2013). 
Registries in the UK have incomplete data on non-melanoma skin cancer, which is often 
underreported, and many patients are treated topically without pathological verification and in 
the private sector (Goodwin et al, 2004; NCIN, 2013). Prostate cancer was excluded because 
the widespread introduction of prostate-specific antigen (PSA) testing since the early 1990s 
introduced difficulties in the interpretation of survival trends (Pashayan et al, 2006). The 
exclusion of non-melanoma skin cancer and prostate cancer is the common procedure in 
calculation of the cancer survival index in England, published annually by the ONS (Office for 
National Statistics, 2012b).  
4 
 
This index was designed to support the evaluation of the effects of early diagnosis, and to 
provide a single summary measure of cancer survival, for the purpose of monitoring the 
effectiveness of the health care system (Quaresma et al, 2015). Breast (women only), bowel 
and lung cancer survival indices were calculated using the same approach. These types of 
cancer were selected because they are associated with the highest incidence and the highest 
mortality in Europe (Ferlay et al, 2013).  
The total number of cancer patients used to construct the survival index and site-specific 
indices was 133,413, which was the number or residents in PCTs included in our analysis who 
were diagnosed with cancer in 2010. Out of this number 13,475 (10%) were female breast 
cancer patients, 21,902 (16%) were bowel cancer patients, 21,510 (n=16%) were lung cancer 
patients, and 76,526 (57%) of patients diagnosed with other types of cancer. The cancer 
survival indices at PCT level, were linked to the cancer awareness and barriers measures by 
the corresponding PCT.  
Statistical analysis 
The awareness and barriers scores were analysed as continuous variables, and their 
association with the cancer survival index was assessed using scatter plots and linear 
regression (at p<0.05 level). The survival index was the dependent variable. Scatter plots were 
also used to visually assess the association between breast, bowel, and lung cancer survival, 
and their cancer-specific symptoms, including ‘unexplained lump or swelling’, ‘persistent 
cough or hoarseness’, and ‘change in bowel or bladder habits’, respectively. Associations 
between cancer survival indices and individual cancer symptoms, and individual barriers were 
also assessed using linear regression. In regression models, each PCT was weighted using 
the inverse variance of the cancer survival estimate. We defined different levels of the barriers 
score based on the interquartile range (IQR). We considered barriers below 25th percentile 
as ‘low’, between 25th and 75th percentile as ‘intermediate’ barriers, and above 75th percentile 
as ‘high’ barriers. The same procedure was used for the awareness score. Maps were also 
developed using 25th and 75th percentiles to determine the cut-off points for low, intermediate 
and high scores. We calculated the statistical power to detect the effects in our regression 
analysis using a post-hoc power calculator (http://clincalc.com/Stats/Power.aspx), and 
reliability of cancer awareness and barriers scores between PCTs, using one-way ANOVA. 
We analysed data using Stata 14.0 (STATA Corp, 2015) and ArcGIS for Desktop Advanced 
10.3 software (Environmental Systems Research Institute, 2014).  
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RESULTS 
 
Our dataset included 52 PCTs spread across England (Table 1). The mean cancer symptom 
awareness score was 7.2 (range: 4.8-8.3, the interquartile range (IQR): 6.9, 7.6). The mean 
barriers to help-seeking score was 1.7 (range: 0.6-3.1, IQR: 1.4, 1.8). One-year cancer 
survival index had a mean value of 66.9 (range 60.5 to 71.7).  
 
Table 1: (About here) 
  
Geographical variation in cancer awareness and barriers to help-seeking 
in England 
 
 
The lowest cancer awareness scores were observed in Tower Hamlets (4.8), Newham (5.5), 
Redbridge (6.4), Gloucestershire (6.5), and Lambeth (6.5). The highest awareness scores 
were observed in Peterborough (8.3), Bedfordshire (8.1), Great Yarmouth and Waveney (8.1), 
and Cambridgeshire (8.0) (Figure 1).  
In England different PCT were ranked according to their socio-economic deprivation, based 
on the income domain of the English indices of Deprivation (Department for Communities and 
Local Government, 2011). PCTs ranked as some of the most socio-economically deprived 
were: Newham and Tower Hamlets in East London, Bradford and Airedale and Kirklees in 
Yorkshire, Lambeth and City and Hackney in London, and Hampshire in Southern coast of 
England. PCTs ranked as some of the least socio-economically deprived were:  Herefordshire 
in West Midlands, Bedfordshire in the East of England, Richmond and Twickenham in London, 
and Great Yarmouth and Waveney in the East of England.  
 
Figure 1: (About here) 
The highest barriers scores observed in Tower Hamlets (3.1), Kirklees (3.1), Bradford and 
Airedale (3.0), and Newham (2.7). The lowest barriers scores were observed in North 
Tyneside (0.6), Northamptonshire (0.8), Newcastle (0.9), and Herefordshire (1.1) (Figure 2).  
Figure 2: (About here) 
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Cancer awareness and barriers scores in relation to cancer survival 
 
There were large differences between survival from different types of cancer – breast cancer 
survival ranged from 93% to 99%, bowel cancer survival ranged from 67% to 81%, and lung 
cancer survival ranged from 18% to 42%.  
Scatter plots showed the position of each PCT with regard to their cancer survival and cancer 
awareness score, or recognition of cancer-specific symptoms (Figure 3); and, cancer survival 
and barriers score (Figure 4). There was a considerable variation in assessed variables across 
PCT areas. We observed a trend with the best scores in PCTs such as Bedfordshire and 
Cambridgeshire, and the worst scores in Tower Hamlets and Newham PCTs. The outliers in 
most scatter plots were Tower Hamlets and Newham PCTs, but even after excluding these 
outliers, similar trends remained in the scatter plots. 
Figure 3: (About here) 
Figure 4: (About here) 
The association between the cancer awareness score and the cancer survival index was 
statistically significant (estimated slope=1.56, 95%CI: 0.56; 2.57, p=0.01) (Table 2). Each 
additional symptom recognised was associated with a 1.56% increase in the cancer survival 
index. Recognition of seven out of nine individual cancer symptoms was statistically 
significantly associated with a slight increase in cancer survival index (Table 2). For example, 
for every 1% increase in the recognition of unexplained lump or swallowing among people 
living in these PCTs there was a 0.15 increase in cancer survival index (Table 2). For every 
1% increase in the recognition of unexplained weight loss among people living in these PCTs 
there was a 0.13 increase in cancer survival index (Table 2). We found no trends (Figure 3) 
or statistically significant associations (Table 2) between survival from breast, lung, or bowel 
cancer, and the awareness score or recognition of each cancer symptom. 
Table 2: (About here) 
The barriers score was not associated with the cancer survival index (estimated slope=-0.14, 
95% CI: -1.28; 0.99, p=0.80), but it was associated with breast cancer survival: each additional 
barrier reported was associated with 0.66% decrease in the breast cancer survival (estimated 
slope=-0.66, 95%CI: -1.20; -0.11, p=0.02) (Table 2). Most individual barriers had an inverse 
association with breast cancer survival. We found no statistically significant associations 
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between the barriers score or individual barriers, and lung and bowel cancer survival. Similar 
statistically significant associations were obtained after we excluded from regression models 
the two outliers, Tower Hamlets and Newham PCTs (data available on request). 
Discussion 
We found geographical variation in symptom awareness and barriers to help-seeking across 
England, with the lowest scores observed in socio-economically deprived parts of East 
London. Low cancer symptom awareness was associated with poor cancer survival index for 
all cancers combined, and high barriers to seeking medical help were associated with poor 
survival from breast cancer, at PCT level in England.  
Strengths and limitations 
This is the first study to examine geographical variation in cancer awareness and barriers to 
help-seeking in England, and to link these with cancer survival data. All measures, predictors 
and outcomes, were standardised using the same age- and sex standardised weights. This 
means that the cancer awareness and barriers score in each PCT were weighted differently 
depending on the age and sex structure of the survey population in each PCT. The cancer 
survival indices were standardised by age, sex, and type of cancer in each PCT, to adjust for 
changes over time in the distribution of cancer patients in these categories. This approach 
was necessary, because cancer survival varies widely depending on these factors (Quaresma 
et al, 2012). Therefore, the cancer survival indices were not affected by changes over time in 
the proportion of cancers of different lethality by sex, such as an increase in breast cancer and 
a reduction of lung cancer incidence. In addition, the survival indices were not affected by 
different age distribution of the cancer patient population, or a shift in the proportion of men 
and women diagnosed with a given type of cancer (Office for National Statistics, 2012c; 
Quaresma et al, 2012). We analysed only PCTs with 90+ participants, and available data in 
all sex and age groups, to allow reliable calculations of the scores. A validated measure of 
public cancer awareness (Stubbings et al, 2009) was used to interview participants included 
in a large population-based sample.  
The matching of surveys with survival data of patients diagnosed in 2010 when most of the 
surveys were carried out, reduced a possible bias that would happen if patients had more 
opportunities to improve their cancer awareness than survey participants. For example, 
several regional campaigns were run in England during 2011, and the first large national 
campaigns, aimed at improving awareness about lung and bowel cancer symptoms were 
introduced in 2012 (Ironmonger et al, 2014). To the best of our knowledge there were no large-
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scale awareness raising campaigns in England prior to 2010. If fact, most of the CAM 
questionnaires were used by cancer networks as a preliminary assessment prior to launching 
various cancer awareness campaigns. We used a one-year cancer survival, which is the most 
commonly used proxy measure for late presentation (Møller et al, 2011). This is because most 
excess deaths in the English patients diagnosed with breast (Møller et al, 2010), lung (Cheyne 
et al, 2013) and bowel cancer (Møller et al, 2012) occur in the first year after diagnosis. Our 
study provides some support to the NAEDI hypothesis, which proposed that the main reasons 
behind late diagnosis, associated with poor survival, are low cancer awareness and increased 
barriers to help-seeking (Hiom, 2015; Richards, 2009).  
As with any ecological study, our study may be subject to what has been called the ecological 
fallacy, which can occur if we assume that inferences based on group-level analyses are 
applicable at the individual level (Piantadosi et al, 1988). For example, it would be incorrect to 
assume that by simply increasing awareness about an additional cancer symptom would mean 
that a person can expect an increase in cancer survival by 1.65 percentage point (if and when 
cancer is diagnosed). If a women no longer feels embarrassment in relation to changes in her 
breasts, following a campaign, it does not mean that her expected survival from breast cancer 
will be automatically increased by 0.6 percentage points. In addition, the possibility that these 
associations may be stronger or weaker at the level of individual cancer patients cannot be 
excluded. Although our findings are not directly applicable to individual people, they outlined 
an overall pattern of low cancer survival in small geographical areas with low cancer symptom 
awareness. As such, our findings can be used as a starting point in investigations of the 
complex relationship between symptom awareness, barriers to help-seeking, and cancer 
survival. This is essential prior to embarking on a large and complex investigation based on 
individual-level data. Marmot (1998) argues that ecological analyses are a useful way to 
explore the relationship between social environment and health, particularly as effective 
policies are delivered at a community-wide rather than individual-level.  
 
Our results might not be generalised nationally, because we included only a third of all PCTs. 
However, we included a wide range of environmentally and socio-economically diverse PCTs 
across the country. We have not adjusted our analyses for socio-economic deprivation or 
ethnicity, for a number of reasons. First, at the time when we conducted the analysis survival 
data of different ethnic groups by PCT were not available to us. Therefore, it was not possible 
to include this factor in our analysis. Second, our units of analysis were PCTs, and there was 
a wide variation of socio-economic deprivation within each PCT. Calculating a single 
deprivation score for each PCT may not be valid. This is because on average there are about 
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100,000 people living in each PCT, and some PCTs had over 250,000 residents such as 
Brighton and Hove (Bojke et al, 2001). Adjusting the PCTs for their average socio-economic 
status may not accurately capture material or social resources, especially among culturally 
and ethnically diverse groups. Most large cities in England, such as London, Manchester or 
Lancaster have some poor people living in affluent areas, and vice versa, with contrasting 
housing types in the same neighbourhood, ranging from Victorian semi-detached houses and 
maisonettes, to less popular council flats and ‘towers’ (Cattell, 2001; Popay et al, 2003). 
Therefore, adjusting each geographical area for its average level of socio-economic 
deprivation is not warranted, especially if there are large gaps between the affluent and poor 
residents in that area.  
Third, our surveys had a substantial proportion of participants with missing data on socio-
economic deprivation. If we had decided to use data on socio-economic deprivation to 
calculate the cancer awareness and barriers scores the number of units in our analysis would 
be reduced to 22 only. This is because we would have to remove 30 PCTs, because they did 
not have participants in all five categories of socio-economic deprivation. However, we used 
population life tables that may in part overcome the fact that socio-economic deprivation was 
not accounted for. These life tables took into account different mortality rates of a different 
population groups living in these PCT, during the year 2010 and 2011, and, for example, 
controlled for the fact that the elderly men, with low socio-economic position, have high 
mortality rates. In addition, the use of age- and sex-standardised weights also accounted for 
some of the differences in socio-demographic distribution of people living in these PCTs.  
With statistical power of 80% we were able to detect regression coefficients over 1.44 for 
cancer awareness and over 0.36 for barriers score in relation to the overall cancer survival 
index. For breast cancer survival, with statistical power of 80% we were able to detect 
regression coefficients over 0.79 for cancer awareness and over 0.17 for barriers score. For 
lung cancer survival, with statistical power of 80% we were able to detect regression 
coefficients over 2.76 for cancer awareness and over 0.62 for barriers score. For bowel cancer 
survival, with statistical power of 80% we were able to detect regression coefficients over 2.08 
for cancer awareness and over 0.50 for barriers score. It is possible that some of our results 
were not statistically significant because of lack of power, rather than no association. However, 
it is worth noting that the weighting in the regression model to some extent mitigates the lack 
of power. 
It is important to note that the scores were standardised by age group and sex, which would 
reduce the within-PCT variability. The reliability of the group-level barriers scores was at 
around 0.80 for each age and sex combination, with the exception of the 75+ age group (0.23 
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in men and 0.50 in women). For awareness scores, their reliability was above 0.80 for each 
age and sex combination, with the exception of elderly men (0.55) and elderly women (0.53). 
The relatively low reliability among elderly is related to the small number of participants in the 
75+ age group. This suggests an overall reliability of the PCT-level scores standardised on 
age and sex. 
Comparison with existing literature 
Cancer symptom awareness and barriers to help-seeking varied greatly between geographical 
areas in England, but we did not observe a north-south divide in these scores. The worst 
scores were observed in socio-economically deprived parts of East London, such as Tower 
Hamlets and Newham. There is ample evidence that socio-economically deprived people in 
England tend to have low cancer awareness and numerous reasons to deter them from 
seeking medical help, including embarrassment or difficulties in arranging transport to the 
doctor’s surgery (Niksic et al, 2015; Robb et al, 2009; Waller et al, 2009). A recent Danish 
study corroborated the findings that socio-economic deprivation is strongly associated with 
barriers to help-seeking (Hvidberg et al, 2014). Underprivileged people are also more likely to 
pursue an unhealthy lifestyle, including smoking and low physical activity (Marmot et al, 1991), 
which act to ‘normalise’ early symptoms of disease (Dixon-Woods et al, 2006). They may also 
feel embarrassed to discuss their symptoms with their doctor, due to perceived social distance 
and status differences.  
Another possible explanation for our findings is the role of ethnic minority background, which 
is one of the factors contributing to poor recognition of symptoms and increased barriers to 
help-seeking (Forbes et al, 2011; Niksic et al, 2016). A recent study found that ethnic minorities 
in England had lower cancer symptom awareness and more widespread barriers to seeking 
medical help than White participants (Niksic et al, 2016). Another study carried out in East 
London also reported that South Asian and Black women had significantly lower breast cancer 
awareness than White women (Forbes et al, 2011). Emotional barriers to seeking medical 
help, such as embarrassment and lack of confidence to talk to the doctor, were highest among 
South Asian women. These differences could not be explained by different levels of 
educational attainment or socio-economic deprivation. Socio-economically deprived areas 
often have higher proportion of ethnic minorities, and these two factors in combination may 
have an amplified effect on cancer awareness and barriers to help-seeking. 
Low cancer awareness was associated with low cancer survival at PCT level, with the worst 
results observed in Tower Hamlets and Newham. These boroughs of Inner North-East 
London, together with Hackney, have been described as ‘the unhealthiest place in Britain’, 
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with high levels of unemployment, large ethnic diversity, low levels of social cohesion and the 
largest population growth in the country (East London NHS Trust, 2013). People living in the 
same PCT area are likely to share aspects of their social and lifestyle patterns, and access to 
educational and healthcare facilities, making their health outcomes more similar than those of 
people from different PCTs (Nur et al, 2015). A term ‘place effect’ was coined to describe the 
extent of area effects on individuals’ health (Macintyre et al, 2002). If symptom awareness and 
cancer survival are to be improved, then it can be argued that place effects need to be taken 
into account. Campaigns may be more effective if they are culturally sensitive and socially 
inclusive, with a clear and simple message, translated into languages frequently spoken in the 
community, and if healthcare provision, in terms of both units and personnel, are increased in 
areas with rapidly growing population. Socio-economically deprived areas, which have poor 
cancer survival (Coleman et al, 2004; Rachet et al, 2010), could benefit most from awareness 
rising campaigns. A recent NHS Health and Wellbeing Strategy is an example of the area-
specific approach to improve health outcomes, which includes reducing the risks of developing 
cancer (East London NHS Trust, 2013). 
We found no strong evidence that recognition of the cancer-specific symptoms were 
associated with survival from the corresponding cancers. People may perceive these 
symptoms, such as ‘persistent cough’, as temporary and attribute them to non-cancer causes 
like smoking, having a cold or an allergy. As an alternative explanation, the role of ‘symptom 
clusters’ has also been implicated. Early symptoms of breast, bowel or lung cancer often occur 
in clusters rather than in isolation. A symptom cluster is a relatively stable group of two or more 
related symptoms, occurring simultaneously and independently from other symptom clusters 
(Kim et al, 2005). For example, the cluster of lung cancer symptoms may include thoracic pain, 
cough, hemoptysis, and vomiting (Hamilton et al, 2005a). The cluster of bowel cancer 
symptoms may include rectal bleeding, abdominal pain, diarrhea, and weight loss (Hamilton 
et al, 2005b). The cluster of breast cancer symptoms may include a lump, fatigue, pain, and 
insomnia (Banning, 2007; Gaston‐Johansson et al, 1999). Recognition of a single, cancer-
specific symptom may not be sufficient to produce an effect on survival from that cancer. 
Experiencing a few unexplained symptoms simultaneously, as a cluster, is perhaps more likely 
to have an effect on cancer survival, because it may prompt people to seek medical help.  
The barriers score was not associated with the cancer survival index, but it was associated 
with breast cancer survival. This could be because breast cancer survival was assessed for 
women only, and there is evidence that women are more likely to report barriers to help-
seeking than men (Niksic et al, 2015). Women may perceive numerous reasons to deter them 
from seeking medical help, imposed by socio-cultural norms. Female breasts have a social 
symbolism, linked with their maternal and sexual function. Therefore, breast cancer may be 
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perceived as a violation of femininity, and a source of shame and stigma (Wong & King, 2008). 
Niksic et al (2015) found that women have about 20% higher odds than men to report that 
they would be put off consulting a doctor because of embarrassment, worry about wasting the 
doctor’s time, and perceived difficulty in talking to the doctor. These barriers were found to 
have a strong negative association with breast cancer survival.  
We also need to acknowledge that the regression coefficients were statistically significant for 
most cancer symptoms in relation to the cancer survival index, but not for site-specific indices. 
This may be because of several reasons. First, an attenuation effect due to lower reliability, 
noting that many of the bowel cancer coefficients are about two thirds the size of the overall 
coefficients. Second, good matching between the survival index, which included different 
types of cancer, and awareness score, which included different types of cancer symptoms. 
For example, it would be surprising if we observed that ‘difficulty in swallowing’ was associated 
with breast cancer survival. However, statistically significant association of this symptom with 
the cancer survival index is not surprising because survival from oesophageal cancer is 
included in this index. Third, survival from site-specific cancers was not associated with 
awareness score, as expected, given that this score included a range of different symptoms 
that were not necessarily relevant for individual cancer sites. Fourth, breast, lung and bowel 
cancer survival indices may have lower statistical power to detect effects of cancer symptom 
awareness and barriers on survival.   
Furthermore, the coefficients for the barriers score for overall cancer survival index were close 
to zero, with the coefficients for breast cancer survival generally negative (p<0.05), and for 
lung and bowel cancer generally positive (although not statistically significant). Therefore, it is 
possible that there was some cancelling out effect in that the barriers that were harmful for 
breast cancer survival may well have been protective for the other two cancers. Finally, the 
combination of positive and negative coefficients between overall cancer survival index and 
different barriers to help-seeking suggests that the use of the aggregate barriers score may 
not be warranted. Some barriers may be associated with prompt help-seeking, while other 
barriers may prolong interval to the first medical consultation. If this is true, different barriers 
to help-seeking need to be analysed separately, in order to understand the mechanism behind 
them and their relationship with cancer survival.  
Further studies are required to confirm or refute these findings. More specifically, future 
studies should assess whether the observed associations exist at the individual level, and 
explore the reasons driving these results, such as educational attainment, ethnicity, number 
of doctors per PCT, or access to health care services. Researchers should also focus on 
exploring whether gender differences in cancer awareness and barriers to help-seeking could 
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account for some of the differences in survival from the most common types of cancer. It is 
necessary to understand the role of different barriers to help-seeking in cancer survival, and 
which mechanisms drive these differences. Understanding whether experiencing a cluster of 
cancer symptoms prompts or hinders help-seeking, and whether it is associated with cancer 
survival would be useful.      
Conclusion and implications 
Our study suggests that higher cancer symptom awareness is associated with better cancer 
survival, which may inform future health campaigns and policy decision makers. We 
highlighted areas for improvement, and the relative position of each of the 52 PCTs with regard 
to cancer awareness, barriers to help-seeking and cancer survival. Future campaigns should 
help people to recognise early symptoms of different types of cancer and encourage 
preventive health behaviour, especially in socio-economically deprived areas. Efforts should 
be made to alleviate barriers to seeking medical help in women with symptoms of breast 
cancer.  
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Region Primary Care Trust ID
Awareness 
score*
Barriers 
score* 
Number of 
participants 
Cancer Survival 
Index (%) 
Variance of cancer 
survival index
Weight**
Number of 
patients
Anglia Bedfordshire 1 8.1 1.4 671 65.8 0.10 6.7 2848
Cambridgeshire 2 8.0 1.7 679 70.9 0.07 10.0 4603
Great Yarmouth & Waveney 3 8.1 1.3 518 68.1 0.10 7.2 2143
Norfolk 4 7.5 1.8 498 68.5 0.03 22.2 7064
Peterborough 5 8.3 1.5 537 66.1 0.19 3.4 1148
Suffolk 6 8.0 1.8 624 69.1 0.07 11.0 4960
Central Hampshire 7 7.8 1.5 387 69.9 0.04 16.4 9190
South Isle of Wight 8 7.8 1.6 378 66.5 0.17 4.1 1149
Coast Portsmouth City 9 7.8 1.5 342 65.5 0.16 4.1 1210
Southampton City 10 7.3 1.6 343 65.5 0.22 2.6 1314
East Midlands Northamptonshire 11 6.9 0.8 1939 66.5 0.07 9.0 4182
Humber & East Riding 12 7.7 1.4 1212 69.2 0.09 8.2 2751
Yorkshire Hartlepool 13 7.3 1.5 94 65.4 0.29 2.4 721
Coast Hull  14 7.4 1.4 936 65.2 0.12 5.4 1621
North East Lincolnshire 15 7.7 1.6 1007 67.6 0.17 4.2 1166
North Lincolnshire 16 7.4 1.6 1081 67.9 0.17 4.4 1172
Kent and Eastern & Coastal Kent 17 7.4 1.6 1058 65.4 0.07 10.1 5469
Medway Medway 18 7.2 1.9 1015 61.1 0.14 5.1 1617
West Kent 19 7.5 1.8 775 66.5 0.07 9.0 4378
Mount Hertfordshire 20 7.3 1.2 777 67.7 0.05 12.7 7241
Vernon Luton 21 6.8 1.3 378 63.8 0.19 3.7 1154
North East Barking & Dagenham 22 6.9 1.8 245 60.5 0.32 1.7 879
London City & Hackney 23 6.7 2.2 245 65.1 0.25 2.8 933
Havering 24 7.1 2.1 360 65.5 0.13 4.9 1685
Newham 25 5.5 2.7 193 61.7 0.21 3.0 954
Redbridge 26 6.4 1.8 318 64.3 0.16 3.9 1295
Tower Hamlets 27 4.8 3.1 258 65.1 0.37 1.7 870
Waltham Forest 28 6.6 1.5 274 63.8 0.24 2.6 1159
North Trent Barnsley 29 7.7 1.7 795 66.0 0.18 3.7 1727
Bassetlaw 30 7.7 1.7 811 65.1 0.36 1.9 809
Doncaster 31 7.4 1.7 1217 66.3 0.12 4.9 2233
Sheffield 32 7.6 1.7 2993 69.4 0.09 6.9 3583
North Lincolnshire 33 7.9 1.5 95 69.7 0.07 10.0 5762
of England Middlesbrough 34 7.0 1.3 298 65.8 0.23 3.1 1009
Newcastle 35 7.3 1.0 713 67.3 0.11 5.9 1875
North Tyneside 36 7.5 0.6 242 66.9 0.16 4.1 1538
Northumberland  37 7.8 1.1 283 69.0 0.11 6.0 2412
South East Bexley 38 7.2 2.7 155 67.4 0.13 5.3 1495
London Lambeth 39 6.5 1.2 2144 66.3 0.28 2.3 1159
South Croydon 40 7.3 1.8 824 67.8 0.19 3.2 1834
West Kingston 41 7.1 1.8 830 68.8 0.26 2.5 808
London Richmond & Twickenham 42 7.5 1.9 839 71.7 0.30 2.2 972
Sutton & Merton 43 7.2 2.0 1644 69.1 0.09 7.2 2146
Wandsworth 44 6.7 2.4 841 68.7 0.17 4.2 1304
Three Gloucestershire 45 6.5 2.2 307 68.1 0.07 9.1 4283
Counties Herefordshire 46 7.1 1.1 290 67.5 0.16 4.3 1333
Worcestershire 47 6.6 1.3 386 68.1 0.09 7.2 3982
Yorkshire Bradford & Airedale 48 6.8 3.0 336 68.4 0.08 8.8 2860
Kirklees 49 7.0 3.1 346 66.8 0.09 7.8 2524
Leeds 50 7.3 2.4 272 69.1 0.06 10.2 4947
North Yorkshire & York 51 7.5 1.6 1279 69.9 0.04 18.6 5590
Wakefield District 52 7.6 2.6 226 67.1 0.10 6.7 2352
Total 35308 133413
Region: a region in England, defined using cancer networks.  ID: A sequential PCT identifier.                                                                                                                                                                                                                         
* Standardised for age and sex.  ** Weight = (1/variance(survival)), inverse variance of the cancer survival index, for all cancers combined, in each PCT.                                         Number of 
patients: these were patients diagnosed during 2010 in each PCT with breast, lung, bowel or any other type of cancer (except prostate and non-melanoma skin cancer).  Number of participants: 
these were participants who completed the CAM survey.                                                                    
Table 1: Primary Care Trusts included in the analysis, with cancer awareness and barriers scores, cancer survival index (all cancers combined, year 2010), 
weights applied in regression analyses, and number of survey participants and cancer patients per PCT




Independent variables
Awareness score 1.56 (0.56; 2.57) 0.17 (-0.38; 0.71) 0.58 (-1.34; 2.51) 0.86 (-0.58; 2.30)
Unexplained lump/swelling 0.12   (0.01; 0.24) 0.01 (-0.06; 0.08) 0.02 (-0.19; 0.23) 0.05 (-0.12; 0.22)
Unexplained persistent pain 0.06  (-0.04; 0.15) 0.02  (-0.03; 0.07) 0.02 (-0.15; 0.20) 0.01 (-0.12; 0.14)
Unexplained bleeding 0.11    (0.01; 0.21) 0.00  (-0.05; 0.05) 0.04 (-0.14; 0.23) 0.05 (-0.09; 0.19)
Persistent cough/hoarseness 0.09    (0.01; 0.16) 0.00 (-0.04; 0.04) 0.04 (-0.09; 0.18) 0.07 (-0.04; 0.17)
Change in bowel/bladder habits 0.12   (0.04; 0.16) 0.01 (-0.03; 0.05) 0.03 (-0.11; 0.17) 0.09  (-0.02; 0.19)
Difficulty in swallowing 0.08  (0.02; 0.14) 0.00  (-0.03; 0.03) 0.05 (-0.06; 0.17) 0.06 (-0.02; 0.15)
Change in the appearance of a mole 0.14   (0.07; 0.20) 0.02 (-0.02; 0.05) 0.06 (-0.07; 0.20) 0.09 (-0.01; 0.19)
Sore that does not heal 0.05   (-0.00; 0.11) 0.01  (-0.02; 0.04) 0.01 (-0.11; 0.10) -0.01 (-0.08; 0.07)
Unexplained weight loss 0.12  (0.04; 0.20) 0.02 (-0.02; 0.06) 0.05 (-0.10; 0.21) 0.10  (-0.01; 0.23)
Barriers score   -0.14 (-1.28; 0.99) -0.66 (-1.20; -0.11) 0.94 (-1.03; 2.91) 0.05 (-1.56; 1.67)
Too embarrassed -0.06   (-0.14; 0.02) -0.05  (-0.09; -0.01) -0.01 (-0.17; 0.14) -0.07 (-0.19; 0.04)
Too scared 0.00  (-0.08; 0.09) -0.02 (-0.06; 0.03) 0.00 (-0.15; 0.15) 0.03  (-0.14; 0.09)
Not confident to talk -0.06   (-0.17; 0.05) -0.05 (-0.11; 0.00) 0.04 (-0.16; 0.25) -0.12  (-0.28; 0.04)
Worry about what GP may find  0.03  (-0.04; 0.09) -0.02 (-0.05; 0.02) 0.06 (-0.06; 0.18) 0.02  (-0.08; 0.11)
Worry about other things  -0.03  (-0.12; 0.05) -0.07 (-0.11; -0.02) 0.07 (-0.08; 0.23) 0.02 (-0.11; 0.15)
Transport difficulties  -0.09  (-0.24; 0.06) -0.11 (-0.18; -0.03) 0.03 (-0.22; 0.32) -0.01 (-0.23; 0.21)
Too busy  0.03  (-0.13; 0.06) -0.07  (-0.11; -0.02) 0.07 (-0.10; 0.23) 0.04 (-0.09; 0.18)
Worry about wasting GP's time  0.04  (-0.03; 0.10) -0.04 (-0.07; -0.01) 0.03  (-0.08; 0.14) 0.05  (-0.04; 0.14)
Difficulty talking to GP  -0.08  (-0.18; 0.03) -0.06 (-0.11; -0.00) -0.04 (-0.23; 0.16) -0.15 (-0.30; 0.01)
Difficulty making appointment  -0.01  (-0.09; 0.07) -0.06 (-0.09; -0.02) 0.07  (-0.07; 0.21) -0.01 (-0.12; 0.11)
Table 2: Linear regression coefficients estimating the relationship between cancer survival indices and cancer awareness (score and individual 
symptoms) and barriers to help-seeking (score and individual barriers) at PCT level  
Weights for all cancer survival estimates were used in models where all cancers survival index was an outcome, and cancer-specific 
weights were used in models where outcomes were breast, lung and bowel cancer, respectively. All awareness and barriers scores 
(and individual symptoms/barriers) were standardised for age and sex in each PCT.                                                                                                                                                                                                                                             
Estimates in bold were statistically significant at p<0.05 level (95% confidence intervals).                                                                                   
GP-general practitioner/doctor.                                   
Overall cancer survival 
index 
Breast cancer survival Lung cancer survival Bowel cancer survival
 
